The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1131
May 27, 2002
View Complete Issue         Table of Contents 2019 
Issue 1131
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Botulinum Toxin (Botox Cosmetic) for Frown Lines
May 27, 2002 (Issue: 1131)
Botulinum toxin type A (Botox Cosmetic - Allergan) has received formal approval from the FDA for treatment of glabellar ("frown") lines in adults not more than 65 years old, and is being heavily advertised. Even before this approval, cosmetic use of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1131
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.